Cargando…

Aggressive intravenous hydration protocol of Lactated Ringer’s solution benefits patients with mild acute pancreatitis: A meta-analysis of 5 randomized controlled trials

OBJECTIVE: The aim of this meta-analysis was to determine the role of an aggressive intravenous hydration protocol of Lactated Ringer’s solution in patients with mild acute pancreatitis (MAP). METHODS: A systematic search was conducted in PubMed, EMBASE, Cochrane Library, and China National Knowledg...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Fei, She, Dong, Ao, Qin, Zhang, Shan, Li, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492986/
https://www.ncbi.nlm.nih.gov/pubmed/36160176
http://dx.doi.org/10.3389/fmed.2022.966824
_version_ 1784793596820455424
author Wu, Fei
She, Dong
Ao, Qin
Zhang, Shan
Li, Jin
author_facet Wu, Fei
She, Dong
Ao, Qin
Zhang, Shan
Li, Jin
author_sort Wu, Fei
collection PubMed
description OBJECTIVE: The aim of this meta-analysis was to determine the role of an aggressive intravenous hydration protocol of Lactated Ringer’s solution in patients with mild acute pancreatitis (MAP). METHODS: A systematic search was conducted in PubMed, EMBASE, Cochrane Library, and China National Knowledge Infrastructure (CNKI) to identify randomized controlled trials (RCTs) published before August 19, 2022. The clinical outcomes were evaluated using the standard mean difference (SMD), mean difference (MD), risk ratio (RR), and 95% confidence interval (CI). The primary outcome was clinical improvement, while the secondary outcomes were the development of systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS), relief of epigastric abdominal pain, and length of hospital stay (LoH). Statistical analysis was performed with RevMan 5.4. Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) Working Group system was used to determine the quality of evidences. RESULTS: There were five RCTs with 370 MAP patients included, and the overall methodological quality was moderate. Aggressive hydration protocol was comparable to standard hydration protocol in terms of clinical improvement (RR = 1.33, 95%CI = 0.95–1.87, P = 0.10; very low evidence). Fewer events of SIRS (RR = 0.48, 95%CI = 0.31–0.72, P < 0.001; low evidence) and MODS (RR = 0.34, 95%CI = 0.13–0.91, P = 0.03; moderate evidence) were reported in patients receiving aggressive hydration protocol. Meanwhile, aggressive hydration protocol also significantly relieved epigastric abdominal pain (SMD = −0.53, 95%CI = −0.81 to −0.25, P < 0.001; low evidence) and shorten the LoH (MD = −2.36, 95%CI = −3.17 to −1.55, P < 0.001; low evidence) compared with standard hydration protocol. CONCLUSION: For patients with MAP, aggressive hydration protocol may be more effective than standard hydration protocol at lowering SIRS and MODS rates, relieving epigastric abdominal pain, and shortening the LoH. Due to the small number of studies that are eligible and poor methodological quality of eligible studies, further studies are required to validate our findings.
format Online
Article
Text
id pubmed-9492986
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94929862022-09-23 Aggressive intravenous hydration protocol of Lactated Ringer’s solution benefits patients with mild acute pancreatitis: A meta-analysis of 5 randomized controlled trials Wu, Fei She, Dong Ao, Qin Zhang, Shan Li, Jin Front Med (Lausanne) Medicine OBJECTIVE: The aim of this meta-analysis was to determine the role of an aggressive intravenous hydration protocol of Lactated Ringer’s solution in patients with mild acute pancreatitis (MAP). METHODS: A systematic search was conducted in PubMed, EMBASE, Cochrane Library, and China National Knowledge Infrastructure (CNKI) to identify randomized controlled trials (RCTs) published before August 19, 2022. The clinical outcomes were evaluated using the standard mean difference (SMD), mean difference (MD), risk ratio (RR), and 95% confidence interval (CI). The primary outcome was clinical improvement, while the secondary outcomes were the development of systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS), relief of epigastric abdominal pain, and length of hospital stay (LoH). Statistical analysis was performed with RevMan 5.4. Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) Working Group system was used to determine the quality of evidences. RESULTS: There were five RCTs with 370 MAP patients included, and the overall methodological quality was moderate. Aggressive hydration protocol was comparable to standard hydration protocol in terms of clinical improvement (RR = 1.33, 95%CI = 0.95–1.87, P = 0.10; very low evidence). Fewer events of SIRS (RR = 0.48, 95%CI = 0.31–0.72, P < 0.001; low evidence) and MODS (RR = 0.34, 95%CI = 0.13–0.91, P = 0.03; moderate evidence) were reported in patients receiving aggressive hydration protocol. Meanwhile, aggressive hydration protocol also significantly relieved epigastric abdominal pain (SMD = −0.53, 95%CI = −0.81 to −0.25, P < 0.001; low evidence) and shorten the LoH (MD = −2.36, 95%CI = −3.17 to −1.55, P < 0.001; low evidence) compared with standard hydration protocol. CONCLUSION: For patients with MAP, aggressive hydration protocol may be more effective than standard hydration protocol at lowering SIRS and MODS rates, relieving epigastric abdominal pain, and shortening the LoH. Due to the small number of studies that are eligible and poor methodological quality of eligible studies, further studies are required to validate our findings. Frontiers Media S.A. 2022-09-08 /pmc/articles/PMC9492986/ /pubmed/36160176 http://dx.doi.org/10.3389/fmed.2022.966824 Text en Copyright © 2022 Wu, She, Ao, Zhang and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Wu, Fei
She, Dong
Ao, Qin
Zhang, Shan
Li, Jin
Aggressive intravenous hydration protocol of Lactated Ringer’s solution benefits patients with mild acute pancreatitis: A meta-analysis of 5 randomized controlled trials
title Aggressive intravenous hydration protocol of Lactated Ringer’s solution benefits patients with mild acute pancreatitis: A meta-analysis of 5 randomized controlled trials
title_full Aggressive intravenous hydration protocol of Lactated Ringer’s solution benefits patients with mild acute pancreatitis: A meta-analysis of 5 randomized controlled trials
title_fullStr Aggressive intravenous hydration protocol of Lactated Ringer’s solution benefits patients with mild acute pancreatitis: A meta-analysis of 5 randomized controlled trials
title_full_unstemmed Aggressive intravenous hydration protocol of Lactated Ringer’s solution benefits patients with mild acute pancreatitis: A meta-analysis of 5 randomized controlled trials
title_short Aggressive intravenous hydration protocol of Lactated Ringer’s solution benefits patients with mild acute pancreatitis: A meta-analysis of 5 randomized controlled trials
title_sort aggressive intravenous hydration protocol of lactated ringer’s solution benefits patients with mild acute pancreatitis: a meta-analysis of 5 randomized controlled trials
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492986/
https://www.ncbi.nlm.nih.gov/pubmed/36160176
http://dx.doi.org/10.3389/fmed.2022.966824
work_keys_str_mv AT wufei aggressiveintravenoushydrationprotocoloflactatedringerssolutionbenefitspatientswithmildacutepancreatitisametaanalysisof5randomizedcontrolledtrials
AT shedong aggressiveintravenoushydrationprotocoloflactatedringerssolutionbenefitspatientswithmildacutepancreatitisametaanalysisof5randomizedcontrolledtrials
AT aoqin aggressiveintravenoushydrationprotocoloflactatedringerssolutionbenefitspatientswithmildacutepancreatitisametaanalysisof5randomizedcontrolledtrials
AT zhangshan aggressiveintravenoushydrationprotocoloflactatedringerssolutionbenefitspatientswithmildacutepancreatitisametaanalysisof5randomizedcontrolledtrials
AT lijin aggressiveintravenoushydrationprotocoloflactatedringerssolutionbenefitspatientswithmildacutepancreatitisametaanalysisof5randomizedcontrolledtrials